slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,645
Current window 1,411-1,440
Pages 355
Rows per page 30
Component
1,411-1,440 of 10,645
60
Uses quotes from former employees to discredit the company's technical claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
76
Uses quotes from former R&D employees to undermine the company's technical claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
83
Uses highlighted quotes to emphasize the contradiction.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
84
The slide uses a 'red flag' framing to cast doubt on the company's technical claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
95
Uses Q&A format to present whistleblower testimony.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
102
The slide uses expert quotes to discredit the company's technical claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
123
Uses expert quotes to frame the company's technical claims as a 'fraudulent narrative'.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
126
Uses highlighted quotes from a Yahoo Finance interview to contrast CEO claims with the activist's narrative of deception.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
143
Uses expert quotes to frame the company's technology as a 'pipe dream' due to manufacturing challenges.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
158
The slide uses a 'villain' narrative by citing an ex-employee to undermine the company's core value proposition.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
192
The slide uses a Q&A format to present expert testimony regarding trial unblinding.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
217
Uses expert quotes to debunk the necessity of the company's proprietary drug formulation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
230
The slide uses highlighted text to emphasize key criticisms (soft endpoints, cherry-picking, safety signals).Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
279
The slide uses highlighted quotes from a former senior medical affairs employee to undermine the commercial viability of Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
286
The slide uses highlighted text to emphasize key concerns about cardiac risk, genetic subtypes, and the drug's unknown mechanism of action.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
294
The slide uses direct quotes from a KOL to undermine the company's narrative of drug efficacy and market adoption.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
300
The slide uses a Q&A format to highlight specific quotes from a trial investigator regarding drug safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
329
The slide uses a Q&A format to document expert testimony.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
347
The slide uses a combination of summary text and verbatim Q&A transcripts to highlight negative sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
359
The slide uses direct quotes to undermine the credibility of the company's sales representatives and the drug's market reception.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
375
The slide uses highlighted text to emphasize key phrases from the expert's transcript.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
391
The slide uses a 'quote-sandwich' technique: a summary paragraph followed by verbatim Q&A transcripts with highlighted key phrases.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
397
The slide uses direct quotes to build a case against the company's commercial execution.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
406
The slide uses a Q&A format to highlight physician reluctance.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
03
The slide uses anecdotal evidence to frame the company's leadership as a 'villain' figure, specifically highlighting potential legal and regulatory scrutiny.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts3 hits
17
The slide uses highly charged, aggressive language to frame the company and its leadership as predatory and unprofessional.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.3 hits
18
The slide uses direct quotes to build a narrative of customer churn risk, specifically highlighting the threat of switching to OrganOX.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.3 hits
24
The slide uses a 'villain' framing to attack the company's business model as exploitative of the US healthcare system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions3 hits
58
The slide uses a combination of legal theory and qualitative expert testimony to build a case for anticompetitive behavior.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
103
The slide uses expert testimony to build a case for high customer concentration and potential ethical/business risks.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits